Dr Reddy's-Hatchtech Seal $198m Superlouse Deal
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories will take to market Australian firm Hatchtech Pty Ltd's late-stage, next-generation head lice product in a deal potentially worth up to $200m.